Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

ENT Therapeutics Market Research Reports

Titlepublishedprice

Nasal Polyposis - Pipeline Review, H1 2017

By Global Markets Direct
"...... oms include runny nose, snoring, itchiness, persistent stuffy, facial pain, loss of taste. Risk factors include asthma, cystic fibrosis, Churg-Strauss syndrome and allergic fungal sinusitis. Treatment includes corticosteroids, antihistamines to treat......"
08-Mar-2017$2000

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2017

By Global Markets Direct
"...... nfectious, inflammatory condition that affects the throat and nasal passages. The virus can spread through droplets in the air when someone who is sick coughs, sneezes or talks. Symptoms include sore throat, runny nose, sneezing, fatigue, headache an......"
28-Feb-2017$2000

Otitis Media - Pipeline Review, H1 2017

By Global Markets Direct
"...... d the eardrum that contains the tiny vibrating bones of the ear. Symptoms include ear pain, difficulty sleeping, loss of balance, fever, headache and loss of appetite. Risk factors include age, seasonal factors and exposure to tobacco smoke or high l......"
28-Feb-2017$2000

Global Hearing Disorders Partnering 2010 to 2017

By Current Partnering
"...... br /> The Global Hearing Disorders Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering......"
01-Feb-2017$1495

Tonsillitis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Nasal Congestion-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... rt is to understand the market and pipeline status of the drugs around the Nasal Congestion to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight......"
01-Jan-2017$2000

Otitis Media-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... understand the market and pipeline status of the drugs around the Otitis Media to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report pr......"
01-Jan-2017$2000

Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... nderstand the market and pipeline status of the drugs around the Pharyngitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provi......"
01-Jan-2017$2000

Tinnitus-Pipeline Insights, 2017

By Delve Insight
"...... hase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Delve......"
01-Jan-2017$1250

Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... nderstand the market and pipeline status of the drugs around the Tonsillitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provi......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.